Search results for PX-TA1011

Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade, ProteoGenix, PX-TA1011

Description of Ustekinumab Biosimilar - Anti-Human IL-12 IL-23 mAb - Research Grade General information about Ustekinumab Ustekinumab is a human monoclonal antibody used to treat psoriasis. It is also approved to treat Crohn’s disease and ulcerative colitis among people who have not responded to more traditional treatments. It is a subcutaneous human interleukin 12 and interleukin 23 antagonist. These are naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders. This product is for research use only.